×
About 3,857 results

ALLMedicine™ Polymyositis Center

Research & Reviews  1,849 results

Anti-Polymyositis/Scl Antibodies in Systemic Sclerosis: Clinical Associations in a Mult...
https://doi.org/10.1097/RHU.0000000000001676
Journal of Clinical Rheumatology : Practical Reports on R... Iniesta Arandia N, Espinosa G et. al.

May 3rd, 2021 - To assess the clinical profile of patients with anti-polymyositis/Scl (PM/Scl) antibodies in a cohort of Spanish patients with systemic sclerosis. From the Spanish Scleroderma Study Group database, we selected patients in whom PM/Scl antibodies ha...

UNC13D mutation in a patient with juvenile polymyositis with recurrent macrophage activ...
https://doi.org/10.1093/rheumatology/keab391
Rheumatology (Oxford, England); Yang X, Yao H et. al.

Apr 30th, 2021 - UNC13D mutation in a patient with juvenile polymyositis with recurrent macrophage activation syndrome.|2021|Yang X,Yao H,Zhao Q,Zhao Q,Yan X,|

Epilepsy as a Comorbidity in Polymyositis and Dermatomyositis-A Cross-Sectional Study.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068784
International Journal of Environmental Research and Publi... Nissan E, Watad A et. al.

Apr 30th, 2021 - Polymyositis (PM) and dermatomyositis (DM) are autoimmune-mediated multisystemic myopathies, characterized mainly by proximal muscle weakness. A connection between epilepsy and PM/DM has not been reported previously. Our study aim is to evaluate t...

Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and fe...
https://doi.org/10.1007/s10067-021-05730-7 10.1016/S0140-6736(08)60955-1 10.1002/hep.28859 10.1016/j.semarthrit.2017.06.004 10.1016/j.jbspin.2017.04.004 10.1056/NEJM197502132920706 10.1002/ana.410380504 10.1212/WNL.0000000000008443 10.1097/MD.0b013e31827f264d 10.1016/j.semarthrit.2018.03.016 10.3899/jrheum.141443 10.1002/mus.26731 10.1161/01.res.84.7.840 10.1093/cvr/cvq195 10.1002/art.1780361020
Clinical Rheumatology; Sabbagh SE, Pinal-Fernandez I et. al.

Apr 14th, 2021 - We analyzed the prevalence of anti-mitochondrial autoantibodies (AMA) in adult- and juvenile-onset myositis longitudinal cohorts and investigated phenotypic differences in myositis patients with AMA. We screened sera from myositis patients includi...

The clinical characteristics and predictors of severe digital ischemia in patients with...
https://doi.org/10.1111/1346-8138.15884
The Journal of Dermatology; Suma H, Yoshida Y et. al.

Apr 13th, 2021 - Severe digital ischemia (SDI), which presents with digital ulcers, necrosis, or gangrene, has been reported to be a rare manifestation of anti-aminoacyl transfer RNA synthetase (ARS) antibody-positive polymyositis/dermatomyositis or anti-synthetas...

see more →

Guidelines  3 results

Treatment consensus for management of polymyositis and dermatomyositis among rheumatolo...
https://doi.org/10.1111/1346-8138.14604
The Journal of Dermatology; Kohsaka H, Mimori T et. al.

Dec 18th, 2018 - Although rheumatologists, neurologists and dermatologists see patients with polymyositis (PM) and dermatomyositis (DM), their management appears to vary depending on the physician's specialty. The aim of the present study was to establish the trea...

2016 American College of Rheumatology/European League Against Rheumatism criteria for m...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496443
Annals of the Rheumatic Diseases; Aggarwal R, Rider LG et. al.

Apr 7th, 2017 - To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM). Expert surveys, logistic regression, and conjoint analysis were used to develop 287 definitions using core set measures. Myositis experts rated greater improvement ...

CONSENSUS STATEMENT: THE USE OF INTRAVENOUS IMMUNOGLOBULIN IN THE TREATMENT OF NEUROMUSCULAR...
http://www.aanem.org/getmedia/e39a0191-ee38-48fe-9b43-e580228825a7/IVIG_CS_2009.pdf
PETER D. DONOFRIO

Sep 17th, 2009 - Consensus statements are important for developing treatment recommendations when evidence- based medicine (EBM) and treatment based on controlled trials is sparse or nonexistent. In this setting, it is clinically helpful to assemble a group of exp.

see more →

Clinicaltrials.gov  1,915 results

Anti-Polymyositis/Scl Antibodies in Systemic Sclerosis: Clinical Associations in a Mult...
https://doi.org/10.1097/RHU.0000000000001676
Journal of Clinical Rheumatology : Practical Reports on R... Iniesta Arandia N, Espinosa G et. al.

May 3rd, 2021 - To assess the clinical profile of patients with anti-polymyositis/Scl (PM/Scl) antibodies in a cohort of Spanish patients with systemic sclerosis. From the Spanish Scleroderma Study Group database, we selected patients in whom PM/Scl antibodies ha...

UNC13D mutation in a patient with juvenile polymyositis with recurrent macrophage activ...
https://doi.org/10.1093/rheumatology/keab391
Rheumatology (Oxford, England); Yang X, Yao H et. al.

Apr 30th, 2021 - UNC13D mutation in a patient with juvenile polymyositis with recurrent macrophage activation syndrome.|2021|Yang X,Yao H,Zhao Q,Zhao Q,Yan X,|

Epilepsy as a Comorbidity in Polymyositis and Dermatomyositis-A Cross-Sectional Study.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068784
International Journal of Environmental Research and Publi... Nissan E, Watad A et. al.

Apr 30th, 2021 - Polymyositis (PM) and dermatomyositis (DM) are autoimmune-mediated multisystemic myopathies, characterized mainly by proximal muscle weakness. A connection between epilepsy and PM/DM has not been reported previously. Our study aim is to evaluate t...

Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and fe...
https://doi.org/10.1007/s10067-021-05730-7 10.1016/S0140-6736(08)60955-1 10.1002/hep.28859 10.1016/j.semarthrit.2017.06.004 10.1016/j.jbspin.2017.04.004 10.1056/NEJM197502132920706 10.1002/ana.410380504 10.1212/WNL.0000000000008443 10.1097/MD.0b013e31827f264d 10.1016/j.semarthrit.2018.03.016 10.3899/jrheum.141443 10.1002/mus.26731 10.1161/01.res.84.7.840 10.1093/cvr/cvq195 10.1002/art.1780361020
Clinical Rheumatology; Sabbagh SE, Pinal-Fernandez I et. al.

Apr 14th, 2021 - We analyzed the prevalence of anti-mitochondrial autoantibodies (AMA) in adult- and juvenile-onset myositis longitudinal cohorts and investigated phenotypic differences in myositis patients with AMA. We screened sera from myositis patients includi...

The clinical characteristics and predictors of severe digital ischemia in patients with...
https://doi.org/10.1111/1346-8138.15884
The Journal of Dermatology; Suma H, Yoshida Y et. al.

Apr 13th, 2021 - Severe digital ischemia (SDI), which presents with digital ulcers, necrosis, or gangrene, has been reported to be a rare manifestation of anti-aminoacyl transfer RNA synthetase (ARS) antibody-positive polymyositis/dermatomyositis or anti-synthetas...

see more →

News  71 results

Consider Home Subcutaneous Immune Globulin for Refractory Dermatomyositis
https://www.medscape.com/viewarticle/946138

Feb 18th, 2021 - Home-based subcutaneous immune globulin therapy is a promising alternative to intravenous immune globulin therapy for patients with refractory dermatomyositis or polymyositis, Anna Postolova, MD, MPH, declared at the 2021 Rheumatology Winter Clini...

Myositis Patients at High Risk of Opportunistic Infections
https://www.medpagetoday.com/rheumatology/generalrheumatology/82747

Oct 15th, 2019 - Among patients with systemic rheumatic diseases, the highest incidence of opportunistic infections was seen in those with polymyositis/dermatomyositis (PM/DM), Taiwanese researchers found. In a nationally representative cohort study, the incidence...

Amyloid PET may help facilitate diagnosis of inclusion body myositis
https://www.mdedge.com/neurology/article/195270/lupus-connective-tissue-diseases/amyloid-pet-may-help-facilitate-diagnosis?channel=39313
Jeff Craven

Feb 27th, 2019 - Amyloid PET imaging may help to accurately identify inclusion body myositis and distinguish it from polymyositis, which could potentially avoid misdiagnosis and unnecessary immunosuppressive medication, according to findings from a small prospecti.

Dr. Lisa Christopher-Stine: Polymyositis? It’s more likely something else
https://www.mdedge.com/neurology/article/194807/lupus-connective-tissue-diseases/dr-lisa-christopher-stine-polymyositis-its/page/0/1?channel=39313

Feb 20th, 2019 - Overlap Sometimes patients with polymyositis also have other rheumatologic conditions that shouldn’t be overlooked, therefore “overlap is its own category,” she said. “In our experience, the most common overlap is scleroderma,” she noted, adding t.

Stroke Risk Doubled in Myopathy
https://www.medpagetoday.com/rheumatology/generalrheumatology/74089

Jul 18th, 2018 - Action Points Be aware that patients with idiopathic inflammatory myopathies have double the risk of both ischemic and hemorrhagic stroke compared to the general population, according to a Swedish population-based cohort study. Note that the idiop...

see more →

Patient Education  19 results see all →